It induces G1 phase arrest in human breast cancer when tested on the Michigan cancer foundation (MCF)-7 cells and reduces the phosphorylation level of protein kinase B (AKT) and Glycogen synthase kinase-3β (GSK3β). This evidence concerns the gene AKT1 and cancer.